Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer cell cytotoxic effectors refer to the set of molecules and cellular pathways through which NK cells mediate destruction of target cells. The main effectors include cytotoxic granules containing perforin and granzymes, which induce target cell apoptosis via granule exocytosis; death receptor ligands such as Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL), which engage death receptors on target cells leading to programmed cell death; and engagement of antibody-dependent cellular cytotoxicity (ADCC) via the CD16 (FcγRIII) receptor, resulting in the killing of antibody-coated cells. NK cell cytotoxicity is a core mechanism in immune defense against infected or transformed cells and is essential in cancer surveillance, infection control, and in modulating immune responses, but this functional umbrella is not itself a discrete molecular target[1][2][3][7][8].
Granule exocytosis induction (perforin/granzyme pathway); Death receptor activation (via Fas ligand, TRAIL); Enhancement of antibody-dependent cellular cytotoxicity (ADCC, via CD16/Fc receptor)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural killer cell cytotoxic effectors.